Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
+24.6M
-
Total reported value, excl. options
-
$1.04B
-
Value change
-
+$1.04B
-
Number of buys
-
75
-
Price
-
$42.56
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q2 2020
75 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q2 2020.
Legend Biotech Corp - COMMON STOCK (LEGN) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 367M outstanding shares and own 6.7% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3.56M shares), Hudson Bay Capital Management LP (3.06M shares), RA CAPITAL MANAGEMENT, L.P. (2.48M shares), CAPITAL INTERNATIONAL INC (2.02M shares), Johnson & Johnson Innovation - JJDC, Inc. (1.63M shares), MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (1.2M shares), ALLIANCEBERNSTEIN L.P. (1.07M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.04M shares), PRICE T ROWE ASSOCIATES INC /MD/ (849K shares), and Capital International Investors (694K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.